ASTRO 2025 | SAN FRANCISCO, CA

SCIENTIFIC EVIDENCE

September 27 – October 30, 2025

ORAL Presentations

MONDAY, SEPTEMBER 29 5:10 PM \| ROOM 154	First-in-Human Dual Modality Radiotherapy Treatment in a Single Plan Using Biology-guided Radiotherapy: A Case Report Henry Park, MD, MPH, Yale VIEW HERE
MONDAY, SEPTEMBER 29 5:20 PM \| ROOM 154	Clinical Outcomes of Biology-guided Radiation Therapy for Osseous Metastases Pule Wang, MD, City of Hope VIEW HERE
WEDNESDAY, OCTOBER 1 12:20 PM \| ROOM 159	A Prospective Pilot Study of [18F]-FDG Imaging with the PET-CT Subsystem on a Biology-guided Radiotherapy Machine Chunhui Han, Ph.D., City of Hope VIEW HERE

FEATURED POSTERS

SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Volume-Scaled Maximum Standard Uptake Value (SUVmax) as an Indicator for Successful Biology-guided Radiotherapy Delivery Murat Surucu, Ph.D., Stanford VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Feasibility of Combining Same-Day Biology-guided Radiotherapy (BgRT) and Stereotactic Body Radiotherapy for Patients with Oligometastatic Disease on a PET-LINAC Platform Bin Cai, PhD, UT Southwestern VIEW HERE
SUNDAY, SEPTEMBER 28 4:45 PM \| HALL F	Biology-guided Radiotherapy for Lung and Bone Tumors: Early Insights Into Local Control Outcomes From the Prospective PREMIER Registry Tu Dan, MD, VIEW HERE
MONDAY, SEPTEMBER 29 5:00 PM \| HALL F	A Multi-Institutional Evaluation of a Novel PET and Dose Congruence (PDC) Metric for Biology-guided Radiotherapy Murat Surucu, Ph.D., Stanford VIEW HERE
TUESDAY, SEPTEMBER 30 12:45 PM \| HALL F	Evaluating the Use of 68Ga-PSMA for Biology-guided Radiotherapy (BgRT) Treatment on PET-LINAC Platforms Neil Desai, MD, UT Southwestern VIEW HERE

POSTERS

SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	A Dosimetric Comparison Between BgRT-SABR Plans and C-Arm LINAC-Based IGRT-SABR Plans for Lung and Bone Lesions Daniel Pham, PhD, CMD, Stanford VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Variations of PET Metrics for Target and Surrounding Tissue Metabolic Activity in the Course of Biology-guided Radiotherapy for Bone and Lung Lesions Chunhui Han, PhD, City of Hope VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Single Fraction SBRT Using a SIB Approach Delivered by BgRT to a Lumbar Spine Metastasis: A Novel Multimodality Planning Strategy Combining BgRT and IGRT Sean Shirvani, MD, MPH, RefleXion VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Effects of Biology Tracking Zone Size on Biology-guided Radiotherapy With and Without Setup Margins for PET-Avid Bone Lesions Chunhui Han, PhD, City of Hope VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	Hybrid Single Target: A New Strategy of Jointly Optimized Planning and Delivery for Biology-guided Radiotherapy and Image-guided Radiotherapy Sean Shirvani, MD, MPH, RefleXion VIEW HERE
SUNDAY, SEPTEMBER 28 2:30 PM \| HALL F	A Feasibility Study for Pediatric Total Marrow Irradiation on a Novel Ring Gantry-Based Radiotherapy System Qiuyun Xu, PhD, City of Hope VIEW HERE
MONDAY, SEPTEMBER 29 3:00 PM \| HALL F	Early Insights Into Potential Clinical Benefits of Biology-guided Radiotherapy for Breast Cancer Dorine de Jong, PhD, RefleXion VIEW HERE

SCINTIX THERAPY

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

LEARN MORE

DISCLOSURES

As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.